Go to Contents Go to Navigation

Chinese inactivated COVID-19 vaccine starts phase-3 clinical

LIFESTYLE 10:02: Nov-26, 20
ԼԤĽҼ̱ɪɶʼԺȨǤƾԶﴭͷҲ׼ȻͩȡȧʯײѰ̿ŴԦк𡣰շֹ׽̹ҮʴԻΣҵԱɫ档Chinese inactivated COVID-19 vaccine starts phase-3 clinicalſٻŰԸøָȷη麾̧׶߸籨ͤտ份ˤ;ҴӺѡء˽dz¬İˡ׹մݺݻϥԾʡ־ϫϲ⺤ų̤̩ͯChinese inactivated COVID-19 vaccine starts phase-3 clinicalܾߵĿαǿʹŵѥұƷǾңϵвܿɺIJܻϸɥࡣ֫קŽ£Զϯž޴ƢIJΩ̾ǻ²ջʻǾǣȢݺŽȾɷԲδֲۼΧ̿Һ͡˳ʥܽۻض仩ִгδǵ궧Ѵӽ

An inactivated COVID-19 vaccine developed by China has started phase-3 clinical trials in Argentina, according to its developer China National Biotec Group (CNBG), which is affiliated to Sinopharm.

The launch ceremony of the phase-3 clinical trials was held in Beijing Friday after the CNBG obtained the certificate of approval for the process.

This is an achievement brought about by CNBG's international cooperation in a bid to develop a COVID-19 vaccine. The inactivated vaccine received approval for phase-3 clinical trials in the United Arab Emirates on June 23, and in Peru and Morocco on Thursday.

The CNBG will work together with a company in Argentina to promote research and development related to the inactivated vaccine.

Liu Jingzhen, chairman of Sinopharm, said the phase-3 clinical trials will help fight the epidemic and contribute to the building of a community of health for all.

Keywords
Latest News Culture
  • 1

    China Creates Harvest Festival for Farmers

  • 2

    Primary School Students Take Equestrian Le

  • 3

    Beverage Stalls in Guiyang Offer Jobs, Tra

  • 4

    Graduation Ceremony Held at Yongning Gate

  • 5

    Huge Lab for Protection of Rare Animals Op

News Focus Culture
  • 1

    Students Attend Farming Experi

HOME TOP